Infection Surveillance Solutions Market Size, Share & Trends Analysis, By Component (Software (On-Premise Software and Web Based Software) and Services (Training & Consulting Services, Implementation Service, and Others)), Infection Type (Surgical Site Infections (SSI), Blood Stream Infections (BSI), and Others), End-use, By Region, Forecast Period 2023 – 2030. (Updated Version Available)

Report ID - MRC_1982 | Pages - 237 | Category - Healthcare IT

Key Market Overview:

Infection Surveillance Solutions Market size was worth USD 423.4 Million in 2022, accounting for a CAGR of 12.2% during the forecast period (2023-2030), and the market is projected to be worth USD 1,034.43 Million by 2030.

An infection surveillance solution is a software application designed to monitor, track and analyze healthcare-associated infections (HAIs) in real time. The solution utilizes data from various sources such as electronic medical records, laboratory results, and pharmacy orders, to identify potential outbreaks, track infection rates, and provide insights to help healthcare facilities make data-driven decisions to prevent the spread of infections. Infection surveillance solutions typically provide dashboards and alerts to help healthcare providers quickly identify and respond to potential outbreaks. They may also offer reporting and analytics tools to support infection control teams in monitoring trends and evaluating the effectiveness of infection prevention and control measures.

Infection surveillance solutions are commonly used in hospitals, long-term care facilities, and other healthcare settings to help reduce the incidence of HAIs and improve patient outcomes. They are often integrated with other healthcare information systems, such as electronic health records (EHRs) and clinical decision support systems, to provide a comprehensive view of patient data and support evidence-based decision-making.

Market Dynamics

Drivers:

The increasing prevalence of healthcare-associated infections (HAIs), which is a major global health concern is driving the demand for infection surveillance solutions. As a result, healthcare facilities are facing a surge in the implementation of effective infection control and prevention programs, and infection surveillance solutions are critical tool in these efforts. Furthermore, governments are also implementing initiatives to improve healthcare quality and reduce the incidence of HAIs, creating further demand for infection surveillance solutions. Additionally, advances in healthcare information technology, such as electronic health records (EHRs) and clinical decision support systems (CDSS), have enabled more efficient and accurate collection of infection data, further driving the growth of the infection surveillance solution market.

Restraints:

The implementation and maintenance of infection surveillance solutions are expensive, which retrains healthcare facilities, especially those with limited resources. Furthermore, the need for these solutions to access sensitive patient data raises concerns about data privacy and security, potentially limiting their adoption by healthcare providers. These cost and privacy considerations hamper the widespread adoption of infection surveillance solutions, which restrains the growth of the market globally.

Opportunities:

Advancements in healthcare information technology, particularly in the areas of artificial intelligence (AI) and machine learning, offer significant potential to revolutionize infection surveillance in healthcare facilities. These technologies will improve the speed and accuracy of data collection and analysis, enabling healthcare providers to quickly identify emerging risks and trends related to healthcare-associated infections (HAIs). AI and machine learning helps healthcare providers to implement targeted infection prevention and control measures, reducing the incidence of HAIs and improving patient outcomes more effectively. The integration of these technologies into infection surveillance solutions presents a significant opportunity for healthcare providers to enhance their infection prevention and control efforts and improve overall patient safety.

Infection Surveillance Solutions Report Coverage:

Report Attributes Report Details
Study Timeline 2017-2030
Market Size in 2030 (USD Million) 1,034.43 Million
CAGR (2023-2030) 12.2%
By Component Software (On-Premise Software And Web Based Software) and Services (Training & Consulting Services, Implementation Services, and Others)
By Infection Type Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Central Line-Associated Bloodstream Infections (CLABSI), Catheter-Associated Urinary Tract Infection (CAUTI), and Others
By End-use Hospitals, Clinics, Long Term Care Facilities, Academic Institutes and Others.
By Region North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Key Players Becton, Dickinson and Company, Wolters Kluwer N.V., Premier Inc., RL Solutions, VigiLanz Corporation, Cerner Corporation (Oracle Corporation), CenTrak, Inc. (Halma plc), Ecolab Inc., Medexter Healthcare GmbH, and PointClickCare

 

Market Segmentation:

By Component

Based on components, the infection surveillance solutions market is bifurcated into software and services. The software segment holds the largest market share. This is attributed to the increasing adoption of software packages in healthcare facilities. However, the service segment is anticipated to witness the fastest CAGR over the forecast period. As, the services segment is also essential for the successful implementation and maintenance of the software.

By Infection Type

Based on infection type, the infection surveillance solutions market is categorized into surgical site infections (SSI), bloodstream infections (BSI), urinary tract infections (UTI), central line-associated bloodstream infections (CLABSI), catheter-associated urinary tract infection (CAUTI), and others. Surgical site infections (SSI) hold the largest market share in 2022. Infection surveillance solutions for SSI typically involve the systematic collection and analysis of data on SSI rates in a healthcare facility. This data can be used to identify trends and patterns in SSI rates, determine the effectiveness of infection prevention and control measures, and guide the development of strategies for reducing the incidence of SSIs. Therefore, SSI contributes the largest share in the market. However, urinary tract infections (UTI) is anticipated to witness the fastest CAGR over the forecast period. As, standardized criteria for diagnosing UTIs, regular monitoring of UTI rates, use of EHRs and data management tools, implementation of evidence-based infection prevention measures, and feedback to healthcare providers are provided by infection surveillance solutions.

By End-use

Based on end-use, the market is categorized into hospitals, clinics, long-term care facilities, academic institutes, and others. The hospital segment holds the largest market share as hospitals have a high patient volume, which increases the risk of transmission of infections. Therefore, infection surveillance solutions are crucial for hospitals to identify, monitor, and prevent the spread of infections. In addition to this, hospitals have a higher budget for implementing infection surveillance solutions compared to other healthcare settings. However, long-term care facilities are expected to be the fastest-growing segment in the infection surveillance solution market. This is due to the increasing elderly population and the higher risk of infections in this setting. Long-term care facilities, such as nursing homes, provide care to a population that is more susceptible to infections due to their age and underlying medical conditions.

By Region

Based on region, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest market share in the infection surveillance solutions market. This is attributed due to the high prevalence of healthcare-associated infections (HAIs) in the region, coupled with well-established healthcare infrastructure and high levels of adoption of healthcare information technology. Furthermore, the Asia Pacific region is expected to grow with the fastest CAGR. This is due to the increasing demand for healthcare services in emerging countries, such as China and India, and a growing focus on infection prevention and control in healthcare facilities.

Infection Surveillance Solutions Market Competitive Landscape:

The market is highly competitive, with a large number of players operating at the global and regional levels. The players compete on various parameters such as price, quality, innovation, and customer service. They are constantly investing in research and development to improve their products and expand their market share. Mergers, acquisitions, and partnerships are also common strategies employed by companies to enhance their market position and expand their product portfolio. Key players in the market include-

Recent developments

  • In September 2022, the BD Foundation, which is the charitable arm of medical technology company BD (Becton, Dickinson, and Company), has announced a three-year investment commitment to support the growth of National Nursing Associations (NNAs) across 21 African countries. The aim of this initiative is to promote health equity and advance nursing education in the region. This demonstrates BD’s commitment to giving back to the communities they serve and to supporting the development of healthcare infrastructure in Africa.
  • In June 2021, VigiLanz, a clinical surveillance company, launched a new audit solution called VigiLanz Audit, which complements their existing safety, quality, and risk products. This enterprise software platform streamlines and automates audit processes, helping hospitals identify emerging risks, improve quality, and save time and resources. VigiLanz Audit is a valuable addition to their suite of products for hospitals seeking to optimize their operations and minimize risk.

Table of Content

To check our Table of Contents, please mail us at: [email protected]

Research Methodology

The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.

Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.

Infection Surveillance Solutions Market Size, Share & Trends Analysis, By Component (Software (On-Premise Software and Web Based Software) and Services (Training & Consulting Services, Implementation Service, and Others)), Infection Type (Surgical Site Infections (SSI), Blood Stream Infections (BSI), and Others), End-use, By Region, Forecast Period 2023 – 2030. (Updated Version Available)
Back to top button